Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.04.18
独立董事候选人声明（解冻）
2014.04.15
2014年第一季度业绩预告
2014.04.11
北京市中伦律师事务所关于公司重大资产购买之实施情况的法律意见书
2014.04.11
董事会关于重大资产重组的实施情况报告书
2014.04.11
华英证券有限责任公司关于公司重大资产购买实施情况之独立财务顾问核查意见
2014.03.29
北京市中伦律师事务所关于公司重大资产购买的法律意见书
2014.03.29
华英证券有限责任公司关于公司重大资产购买之独立财务顾问报告
2014.03.29
北京市中伦律师事务所关于公司重大资产购买的补充法律意见书（一）
2014.03.29
北京市中伦律师事务所关于公司重大资产购买的补充法律意见书（二）
2014.03.29
关于重大资产重组方案获得中国证监会核准的公告
第一页
上一页
114
115
116
117
118
下一页
最后一页
